- The One Study: Grady 1993 and Its Immunological Claims
- Ricinoleic Acid: Real Pharmacology, Unverified Delivery
- Kennedy et al. 2011: Cochrane Review on Castor Oil for Labor Induction
- Arslan and Inal 2012: Oral Castor Oil for Constipation in the Elderly
- The Complete Absence of Pack-Specific RCT Evidence
The One Study: Grady 1993 and Its Immunological Claims
If you follow the citation trail for castor oil packs' immune-boosting claims — and it is a short trail — you arrive at a single document: a 1993 paper by Harvey Grady published in the Journal of Naturopathic Medicine. The paper, titled "Immunomodulation Through Castor Oil Packs," enrolled 36 healthy adult volunteers and measured T-lymphocyte counts before and after two-hour castor oil pack applications. The treatment group showed an increase in CD4+ T-lymphocyte counts (T-11 cells, sometimes called helper T-cells in the older nomenclature the paper uses) compared to the placebo group, which received packs soaked in peanut oil.
Before the positive finding is processed, the study's design limitations require equal attention. The sample size was 36 total participants, producing small treatment and control groups with limited statistical power. The study had no blinding — participants knew which type of oil they were receiving, introducing placebo and expectation effects into immune measurements that are known to be sensitive to psychological state. The measurement window was two hours post-application, capturing an immediate acute response rather than any sustained immunological effect. The study was published in a naturopathic journal, not peer-reviewed in a mainstream immunology or clinical medicine journal with the methodological rigor those venues require. And critically: in the 30+ years since publication, no independent research group has attempted to replicate the finding. One unreplicated small study in a specialty journal is not the evidentiary foundation for a billion-dollar wellness category.
The Grady paper's continued citation across naturopathic medicine websites, castor oil pack marketing, and wellness influencer content illustrates a common pattern in alternative medicine: a single modest study, conducted without rigorous controls, becomes permanently embedded in the citation ecology of a practice and is cited with a confidence that bears no relationship to the study's actual strength. "A clinical study found that castor oil packs increase T-lymphocyte activity by 28%" is technically traceable to Grady 1993. It is also a description that makes the evidence sound more robust than a 36-person unblinded two-hour study in a naturopathic journal in 1993 actually is. The gap between the strength of the citation and the strength of the study is the gap between the evidence and the claim.
Ricinoleic Acid: Real Pharmacology, Unverified Delivery
The one genuinely established pharmacological fact about castor oil is that its primary fatty acid, ricinoleic acid (comprising approximately 90% of castor oil's fatty acid content), has real biological activity. Vieira et al. published research in 2000 establishing that ricinoleic acid binds to the EP3 prostanoid receptor, inhibiting substance P and other nociceptive mediators to produce anti-inflammatory and analgesic effects. This mechanism is legitimate — prostanoid receptor modulation is well-established pharmacology, and ricinoleic acid's activity at EP3 distinguishes it from other vegetable oils. The anti-inflammatory effect of topically applied castor oil has some supporting evidence in dermatological applications: a 2009 study in Biological and Pharmaceutical Bulletin found anti-inflammatory effects in mouse ear edema models with topical ricinoleic acid application, and castor oil is used in pharmaceutical formulations as an excipient and vehicle for drug delivery precisely because of its skin-penetrating and emollient properties.
The critical gap is between "ricinoleic acid has pharmacological activity" and "ricinoleic acid penetrates skin through flannel fabric in sufficient concentrations to reach the liver and produce a detoxification effect." This is a pharmacokinetic question — what is the transdermal absorption rate of ricinoleic acid through fabric-mediated application, and does absorbed concentration reach the liver at biologically meaningful levels? This question has not been answered by peer-reviewed pharmacokinetic research. Skin is an effective barrier specifically because it limits transdermal absorption of large, lipophilic molecules like ricinoleic acid (molecular weight ~298 g/mol). Pharmaceutical transdermal drug delivery systems — patches for fentanyl, nicotine, hormones — work either because the active compound is small enough to penetrate skin readily, or because pharmaceutical technologies (chemical enhancers, nanocarriers, microneedles) are used to overcome the barrier. A wool flannel cloth does none of this. The assertion that ricinoleic acid penetrates skin through unmodified fabric at sufficient levels to reach the liver is a hypothesis, not an established fact.
This distinction is important because the ricinoleic acid mechanism is frequently cited as the "scientific basis" for castor oil packs' efficacy. "Ricinoleic acid has anti-inflammatory properties" is true. "Castor oil packs deliver ricinoleic acid transdermally to the liver to produce anti-inflammatory detoxification" is an extrapolation with no pharmacokinetic evidence. The mechanism exists; the delivery vehicle is unvalidated.
Kennedy et al. 2011: Cochrane Review on Castor Oil for Labor Induction
A 2011 Cochrane systematic review by Kennedy and colleagues examined the evidence for castor oil as a method of cervical ripening and labor induction in term and post-term pregnancies. This is a distinct application from packs — oral castor oil ingestion, not topical pack application — and the biological mechanism is different: oral castor oil is metabolized to ricinoleic acid in the small intestine, which stimulates smooth muscle contraction through prostaglandin-mediated pathways, a mechanism plausibly connected to uterine contraction.
The Cochrane review identified three eligible randomized trials with a combined enrollment of 233 women. The reviewers concluded that the evidence was insufficient to support or refute castor oil for labor induction, citing the small number of trials, the small sample sizes, methodological limitations, and inconsistent reporting of important outcomes. Castor oil was associated with nausea in approximately 90% of women who received it, which itself represents a non-negligible harm in the labor induction context. The review's conclusion — insufficient evidence — applies to oral castor oil for labor induction, not to topical packs. Its relevance to the pack literature is that even for the oral route, where ricinoleic acid bioavailability is established, clinical evidence for efficacy is inadequate. The pharmacokinetically simpler oral route cannot demonstrate efficacy; the pharmacokinetically unvalidated transdermal pack route has not been subjected to the same level of investigation.
The labor induction use case is nonetheless prominent in castor oil pack communities, where it appears as a specific indication alongside fertility support and menstrual regulation. The community use exceeds the evidence for any route of administration; for the pack route specifically, the evidence is absent entirely.
Arslan and Inal 2012: Oral Castor Oil for Constipation in the Elderly
Arslan and Inal published a study in 2012 in the Journal of Gerontological Nursing examining castor oil for constipation in elderly nursing home residents. The study used oral castor oil (15 mL), not topical packs, in a small sample of elderly institutionalized patients, and found improvements in constipation outcomes compared to control. This study is occasionally cited in castor oil pack literature as evidence for the packs' "digestive benefits," conflating oral castor oil's established laxative properties with a topical pack mechanism.
Oral castor oil's laxative effect is not disputed — it has been used as a stimulant laxative for centuries, operates through well-characterized mechanisms in the small intestine (ricinoleic acid-mediated secretion and motility effects), and was the basis for castor oil's common historical use before modern laxatives became available. The Arslan study adds to a well-established evidence base for oral castor oil as a laxative in specific populations. It says nothing about castor oil packs. The citation of a study on oral laxatives to support the claimed benefits of topical packs illustrates how citation practices in the pack literature conflate pharmacologically distinct applications — a form of evidence laundering where legitimate research on one castor oil application is used to imply clinical support for a mechanistically different one.
The Complete Absence of Pack-Specific RCT Evidence
A systematic search of the peer-reviewed literature as of 2026 finds zero randomized controlled trials on castor oil packs as a specific intervention for any outcome in any population. This is the foundational evidentiary fact that the market has built around rather than on. The claims made for packs — liver detoxification, hormone balance, lymphatic stimulation, fertility support, menstrual pain reduction, adhesion breakdown, immune enhancement — represent a substantial array of proposed therapeutic effects, none of which has been subjected to the minimum scientific test: a controlled trial comparing packs to a credible control condition with pre-specified outcomes and appropriate sample sizes.
The absence of RCTs is not unusual for traditional or folk practices that predate modern clinical trial infrastructure. What is unusual is the active commercial ecosystem — $45-65 branded kits, Queen of Thrones as a multimillion-dollar brand, 500 million TikTok views — built on zero clinical trial evidence, citing a single 1993 unblinded study of 36 people, with a mechanism that lacks pharmacokinetic validation. In the pharmaceutical world, a compound with this evidence profile would not be marketed. In the dietary supplement and wellness product world, it becomes a TikTok phenomenon with 500 million views and a Canadian naturopath's branded empire.